HI
PFE icon

Humankind Investments’s Pfizer PFE Stock Holding History

Humankind Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.08M Hold
211,000
– – 2.43% 13
2026
Q1 		$5.92M Buy
+211,000
New +$5.62M 3.38% 13
2025
Q4 		– Sell
-94,931
Closed -$2.42M – 123
2025
Q3 		$2.42M Sell
94,931
-5,340
-5% -$132K 0.55% 26
2025
Q2 		$2.43M Buy
100,271
+4,892
+5% +$114K 0.59% 25
2025
Q1 		$2.42M Sell
95,379
-3,593
-4% -$94K 0.63% 24
2024
Q4 		$2.63M Buy
98,972
+15,319
+18% +$416K 0.66% 23
2024
Q3 		$2.42M Buy
83,653
+5,709
+7% +$167K 0.87% 19
2024
Q2 		$2.18M Sell
77,944
-22,153
-22% -$610K 0.58% 27
2024
Q1 		$2.78M Buy
100,097
+25,812
+35% +$716K 0.73% 23
2023
Q4 		$2.14M Buy
74,285
+13,406
+22% +$405K 0.63% 27
2023
Q3 		$2.02M Sell
60,879
-598
-1% -$21.1K 0.84% 20
2023
Q2 		$2.25M Buy
61,477
+2,279
+4% +$88.7K 0.88% 18
2023
Q1 		$2.42M Buy
59,198
+6,290
+12% +$272K 1% 14
2022
Q4 		$2.71M Buy
52,908
+2,009
+4% +$96.3K 1.18% 12
2022
Q3 		$2.23M Buy
50,899
+10,720
+27% +$521K 1.07% 15
2022
Q2 		$2.11M Sell
40,179
-1,680
-4% -$85.6K 1.01% 14
2022
Q1 		$2.17M Buy
41,859
+3,640
+10% +$189K 0.89% 16
2021
Q4 		$2.26M Buy
38,219
+2,216
+6% +$110K 0.91% 16
2021
Q3 		$1.55M Sell
36,003
-6,334
-15% -$281K 0.7% 20
2021
Q2 		$1.66M Buy
42,337
+15,300
+57% +$595K 0.78% 17
2021
Q1 		$980K Buy
+27,037
New +$960K 0.57% 19

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Humankind Investments's PFE Position: Q2 2026 in Review

Humankind Investments held its Pfizer (PFE) position steady in Q2 2026 at 211,000 shares worth $5.08M. The position accounts for 2.43% of the portfolio, ranked #13.

Humankind Investments first reported a position in PFE in Q1 2021 and has held it in 21 quarters since. The position peaked at $5.92M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Humankind Investments held 211,000 shares of Pfizer worth $5.08M as of Q2 2026.
  • Humankind Investments left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 2.43% of Humankind Investments's portfolio in Q2 2026, its #13 holding.
  • Humankind Investments first reported a position in Pfizer in Q1 2021 and has held it in 21 quarters since.
  • Humankind Investments's Pfizer position peaked at $5.92M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Humankind Investments's 13F filing for Q2 2026, filed 14 Aug 2026.